Medecins Du Monde Et Al competitive analysis

Explore patent oppositions filed by Medecins Du Monde Et Al against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026
Patent NumberTitleApplicantOpposition Date
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 2, 2019

Latest PTAB cases involving Medecins Du Monde Et Al

Discover the latest PTAB cases involving Medecins Du Monde Et Al, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Medecins Du Monde Et Al with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDECINS DU MONDE ET AL1 - - -
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - 38 - 7